Document is current

Any future updates will be listed below

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Crossref DOI link: https://doi.org/10.1186/s13075-015-0583-8

Published Online: 2015-03-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark